Continuous Peripheral Nerve Block Catheters Market Report 2026

The continuous peripheral nerve block catheters market size has grown strongly in recent years. It will grow from $0.46 billion in 2025 to $0.49 billion in 2026 at a compound annual growth rate (CAGR) of 6%. The growth in the historic period can be attributed to rising number of surgical procedures globally, increasing adoption of regional anesthesia techniques, growing awareness of opioid-related side effects, expansion of hospital pain management services, technological improvements in catheter materials and design.

The continuous peripheral nerve block catheters market size is expected to see strong growth in the next few years. It will grow to $0.62 billion by 2030 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to increasing demand for opioid-sparing pain management strategies, rising adoption of outpatient and ambulatory surgeries, growing geriatric population requiring long-term pain control, expansion of ultrasound-guided interventional procedures, increasing focus on enhanced recovery after surgery protocols. Major trends in the forecast period include increasing adoption of ultrasound-guided peripheral nerve block catheter placement for improved accuracy and safety, rising preference for multimodal and opioid-sparing pain management protocols in perioperative care, growing use of continuous infusion techniques for extended postoperative analgesia, expansion of ambulatory surgical procedures driving demand for long-duration regional anesthesia solutions, increasing focus on enhanced recovery after surgery (eras) programs integrating regional anesthesia techniques.

The rising number of orthopedic surgical procedures is expected to propel the growth of the continuous peripheral nerve block catheters market going forward. Orthopedic surgical procedures refer to medical interventions that involve the treatment of musculoskeletal conditions, including joint replacements, fracture repairs, and ligament reconstructions. The increasing volume of orthopedic surgical procedures is primarily contributing to market growth, driven by the growing aging population, rising incidence of musculoskeletal disorders, and advancements in surgical techniques that improve outcomes and expand access to care. Continuous peripheral nerve block catheters support orthopedic surgical care by enabling continuous and targeted postoperative pain relief, particularly following procedures such as knee and hip replacements, which are associated with significant postoperative pain. For instance, in September 2025, according to the CORE Institute, a US-based provider of orthopedic, spine, neurological, and related musculoskeletal care, an estimated 30.5 million orthopedic surgical procedures were performed globally in 2024, representing a 4.5% increase from the previous year. Therefore, the increasing volume of orthopedic surgical procedures is supporting and propelling the demand for continuous peripheral nerve block catheters market.

The increasing incidence of chronic illnesses is anticipated to support the growth of the continuous peripheral nerve block catheters market in the coming years. Chronic diseases include long-term health conditions such as diabetes, cancer, cardiovascular disorders, arthritis, and neurological conditions that typically require continuous treatment and pain management strategies. Factors such as an aging global population, inactive lifestyles, poor nutrition, and growing obesity levels are contributing to the rising burden of chronic diseases worldwide. Continuous peripheral nerve block catheters play an important role in managing these conditions by providing prolonged and localized pain relief, reducing reliance on opioids, and enhancing patient recovery and comfort, especially during repeated or complex surgical procedures. According to the World Health Organization, chronic diseases were responsible for nearly 74% of deaths globally in 2024, with cardiovascular diseases, cancer, diabetes, and chronic respiratory disorders representing the primary causes. As a result, the growing prevalence of chronic diseases is contributing to increased demand for continuous peripheral nerve block catheters.

Leading companies operating in the continuous peripheral nerve block (CPNB) catheters market are focusing on product innovation and technology integration to improve procedural efficiency and patient outcomes. These advancements include the development of improved catheter securement and delivery systems that enhance stability and reduce complications. For example, in January 2025, B. Braun, a Germany-based medical device company, launched the Clik-FIX Epidural/Peripheral Nerve Block (PNB) Catheter Securement Device, designed to improve catheter fixation and reduce the risk of dislodgement during regional anesthesia procedures, thereby enhancing clinical effectiveness and patient safety.

Major companies operating in the continuous peripheral nerve block catheters market are Stryker Corporation, Becton Dickinson and Company (BD), B. Braun Melsungen AG, Teleflex Incorporated, ICU Medical Inc, Cook Medical, Ambu A/S, Avanos Medical Inc., Vygon SA, Poly Medicure Ltd., Dyna Medical Corporation, Solo-Dex Inc., Shunmei Medical, Medline Industries LP, Scilex Holding Company, Ace Medical, Henan Tuoren Medical Device Co. Ltd., Advin Health Care, Epimed International, Pajunk GmbH, Baxter International.

North America was the largest region in the continuous peripheral nerve block catheters market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the continuous peripheral nerve block catheters market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the continuous peripheral nerve block catheters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The continuous peripheral nerve block catheters market consists of sales of single-orifice catheters, multi-orifice catheters, over-the-needle catheters, and through-the-needle catheters. The market value also includes the sale of related goods, including interceptor missiles, launch systems, radar and tracking equipment, and guidance of electronics. Values in this market are measured at ‘factory gate’ prices - that is, the value of goods sold by manufacturers or creators, whether to other entities (including downstream defense contractors, distributors, and military organizations) or directly to end customers. The value of these goods includes any related services provided by the manufacturers.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.